NOT-EB-21-012: Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"

Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"

Notice Number:

NOT-EB-21-012

Key Dates

Release Date:

April 26, 2021

Related Announcements

NOT-ES-21-007 - Notice of Termination of NIEHS Participation on NOT-EB-21-012

PAR-19-159 - Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Neurological Disorders and Stroke (NINDS)

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to extend the expiration date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)" by one year. PAR-19-159 will now expire on May 8, 2022.

The following section of PAR-19-159 has been modified to reflect the changes:

Part 1. Overview

Key Dates

Currently Reads:

Expiration Date May 08, 2021

Modified to Read (changes shown in bold italics):

Expiration Date May 08, 2022

All other aspects of this PAR-19-159 remain unchanged.

Inquiries

Please direct all inquiries to:

Ihor George Zubal, Ph.D.
National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
Phone: 301-827-5168
E-mail: [email protected]